Aldeyra Therapeutics (NASDAQ:ALDX) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $(0.27) by 7.41 percent. This is a 26.47 percent increase over losses of $(0.34) per share from the same period last year.
Jack Ma’s Ant Signs MoU With Kenanga To Enable Launch Of Malaysia’s First Wealth SuperApp
Alibaba Group Holdings Ltd.’s (NYSE: BABA) financial affiliate Ant Group has signed a memorandum of understanding (MoU) with Malaysia’s Kenanga Investment Bank Berhad under which Kenanga will leverage mPaaS, a m
